Vaccines for the World
Contributor: Miss Chanice Henry
Posted: 05/04/2016
Cold Chain Logo
China’s State Council has passed an amendment on vaccine regulations just weeks after the launch of an investigation into incorrectly handled vaccines took place, in ‘a case that shook the country’. The amendment, which impacts multiple articles within Regulations for the Circulation and Inoculation of Vaccines, was passed on April 24th.Cold c Full Article »
Posted: 08/05/2014
Cool Chain 2015 - Where the Industry Meets to Shape its Future
With over 500 participants from hundreds of different pharmaceutical manufacturers, leading solution providers and cold chain logistics experts, Cool Chain & Temperature Controlled Logistics Europe 2015 is truly an event not-to-be-missed! Full Video »
Contributor: Andrea Charles
Posted: 10/23/2011
The 2 million vaccine preventable deaths do not occur for lack of vaccines, but because of inadequate distribution. In this interview Harvey Rubin, Director of Strategic Threat Analysis and Response at the University of Pennsylvania, speaks to Andrea Charles from Pharma IQ, about the Our Energy for Health Project whose proposal is to use the Full Podcast »
Contributor: Gary Hutchinson
Posted: 06/29/2016
Gary Hutchinson
Clinical trial material (CTM) or investigational medicinal products (IMP) are an important part of the early stages of the life science supply chain. As trials are being run on a global scale, in markets with less than ideal infrastructure, there is a dire need for companies to work with specialized cold chain experts to engineer and design innovative distribution processes. Cold chain failure may lead to: the patient being administered an unsafe product; liability based on compliance infractions; inconsistent data results; or an entire shipment’s product integrity could be rejected by the quality department, resulting in costly delays. Full Column »
Posted: 04/28/2015
Getting Essential Medicines to Customers: Investment in Supply Chains
Recently, the members of the Getting Health Products to People: Alliance for Health Logistics—that seeks to improve health product availability throughout Latin America and the Caribbean (LAC)—produced an infographic for health policymakers. Using this new material, the Alliance members will jointly encourage countries to invest—not only in procuring essential medicines—but also in the public health supply chains that deliver these products to the people who need them.

The graphic demonstrates that by committing between .05-.33 cents to supply chains for every US$ dollar invested in products, countries can strengthen their health programs, better serve their customers, and help meet their development goals. Full Whitepaper »